CompletedNCT00723450
Lamotrigine added to maintenance care for bipolarity in children and teens
About this title
Lamictal as Add-on Treatment for Bipolar I Disorder in Pediatric Patients
Read the official source — NCT00723450Medication studyAges 10–17United States
Understand this study
Who was this study for?
This study was for people with bipolarity. Listed age limits: 10 years to 17 years. Other eligibility criteria applied.
- Listed locations
- Dothan and 45 more locationsSee all locations and recruitment
- Study phase
- Phase 3Usually a larger study designed to confirm effectiveness and safety in a broader group.
Study information
Study start dateJuly 2008
- Recruitment status
- Completed
- Enrollment listed in the registry
- 301
- Sponsor
- GlaxoSmithKline
- Sponsor type
- Unknown or unclear
- Study type
- Drug
- Intervention type
- Drug
- Study phase
- Phase 3Usually a larger study designed to confirm effectiveness and safety in a broader group.
- Locations
- United States
- Age range
- From 10 Years to 17 Years
- Official registry ID
- NCT00723450
- Official title
Show the full official title
The Evaluation of Lamictal as an Add-on Treatment for Bipolar I Disorder in Children and Adolescents, 10 to 17 Years of Age
Looking for a study you can join?
Explore recruiting studiesRecruitment & locations
CompletedThis badge reflects the study status reported by the registry. Check the registry for the latest information.
Dothan · Scottsdale · San Diego
39 more locations
- Stanford
- Washington D.C.
- Bradenton
- Gainesville
- Jacksonville
- Orlando
- Tampa
- Winter Park
- Smyrna
- Libertyville
- Naperville
- Indianapolis
- Overland Park
- Wichita
- Shreveport
- Baltimore
- Boston
- Springfield
- Worcester
- Rochester
- Saint Charles
- Lincoln
- Piscataway
- Albuquerque
- Mount Kisco
- Stony Brook
- Chapel Hill
- Fargo
- Cincinnati
- Cleveland
- Columbus
- Toledo
- Philadelphia
- Dallas
- Houston
- Salt Lake City
- Roanoke
- Kirkland
- Seattle
Interested in joining this study?
Questions about this study
Who is behind this study?
The study sponsor is GlaxoSmithKline.
Did this study involve medication?
Yes. The study involved medication, including lamictal.
Who was this study for?
This study was for people with bipolarity. Listed age limits: 10 years to 17 years. Other eligibility criteria applied.
